← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 1992Last known activity
Jul 12, 2023
Timeline
1970s
- Jan 1, 1970
Gynecologic Oncology Group— Founded
Drugs by trial phase (122 distinct, 219 trials)
Phase 3 (45 own, 0 via acquisition)
Phase 2 (69 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma, Clear Cell
- Adenocarcinoma, Mucinous
- Adenomyoepithelioma
- Anemia
- Brenner Tumor
- Carcinoma
- Carcinoma, Adenosquamous
- Carcinoma, Endometrioid
- Carcinoma in Situ
- Carcinoma, Ovarian Epithelial
- Carcinoma, Small Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Carcinosarcoma
- Cervical Intraepithelial Neoplasia
- Choriocarcinoma
- Communicable Diseases
- Cystadenocarcinoma
- Cystadenocarcinoma, Mucinous
- Cystadenocarcinoma, Serous
- Drug-Related Side Effects and Adverse Reactions
- Endometrial Hyperplasia
- Endometrial Neoplasms
- Fallopian Tube Neoplasms
- Fatigue
- Genital Neoplasms, Female
- Gestational Trophoblastic Disease
- Granulosa Cell Tumor
- Hereditary Breast and Ovarian Cancer Syndrome
- Hydatidiform Mole
- Hyperplasia
- Infections
- Infertility
- Leiomyosarcoma
- Leydig Cell Tumor
- Lymphedema
- Mixed Tumor, Mullerian
- Neoplasms
- Neoplasms by Site
- Neurotoxicity Syndromes
- Neutropenia
- Osteoporosis
- Ovarian Neoplasms
- Papilloma
- Papillomavirus Infections
- Peripheral Nervous System Diseases
- Peritoneal Neoplasms
- Postoperative Complications
- Sarcoma
- Sarcoma, Endometrial Stromal
- Sertoli-Leydig Cell Tumor
- Sex Cord-Gonadal Stromal Tumors
- Small Cell Lung Carcinoma
- Trophoblastic Neoplasms
- Urogenital Neoplasms
- Uterine Cervical Neoplasms
- Uterine Neoplasms
- Vaginal Neoplasms
- Virus Diseases
- Vulvar Neoplasms
Recent trials (50)
- NCT05870748CollaboratorPhase 2Jul 12, 2023
- NCT05257408CollaboratorPhase 3Jun 29, 2022
- NCT05173987CollaboratorPhase 3Feb 3, 2022
- NCT04625270CollaboratorPhase 2Dec 21, 2020
- NCT04634877CollaboratorPhase 3Dec 18, 2020
- NCT04463771CollaboratorPhase 2Dec 15, 2020
- NCT04498117CollaboratorPhase 3Aug 25, 2020
- NCT04393285Lead sponsorPhase 2Jun 1, 2020
- NCT04269200CollaboratorPhase 3Mar 30, 2020
- NCT04209855CollaboratorPhase 3Dec 31, 2019
- NCT03981796CollaboratorPhase 3Jul 15, 2019
- NCT03955471CollaboratorPhase 2Jun 30, 2019
- NCT03786081CollaboratorPhase 1/Phase 2Feb 27, 2019
- NCT03737643Overall official - principal investigatorPhase 3Jan 4, 2019
- NCT03673124Study chairPhase 2Nov 30, 2018
Details
- Founded
- Philadelphia, PA, US Jan 1, 1970
- Last known activity
- Jul 12, 2023